Clinical research companies support the design, execution and management of studies that evaluate the safety and effectiveness of medicines, diagnostics and healthcare technologies. Their work is essential for bringing new products to market.
This category includes companies working on:
Browse 125 UK clinical research companies below.
Independent global health research institute focused on chronic diseases
The George Institute for Global Health (UK) is an independent medical research institute conducting large-scale clinical trials, population studies, and health policy research on non-communicable diseases. Based at Imperial College London's White City Campus and affiliated with Imperial as a strategic partner, the UK…
Biomarker-driven CRO integrating clinical trials and laboratory sciences
Precision for Medicine is a full-service contract research organisation built around biomarker-driven clinical development. The company integrates clinical trial execution with specialty laboratory services, translational science, data management, and biostatistics to support oncology, rare disease, and cell and gene…
Decentralised clinical trial site bringing research to participants
The Virtual Clinical Trial Centre is a clinical research organisation operating a network of flexible, patient-centric trial sites across the UK and Spain. Its decentralised model allows participants to engage in clinical research from home or local sites, addressing the geographic and logistical barriers that limit…
Clinical trial supply and early access programmes for unapproved medicines
Bionical Emas is a specialist services company supporting pharmaceutical and biotechnology companies with access to medicines during and around clinical development. Its clinical trial supply business sources commercially available medicines, comparators and ancillary materials for studies worldwide. Its early access…
AI operating system connecting pharma drug development decisions end-to-end
Perceptic is a UK software company that has built an AI platform connecting decision-making across the drug development lifecycle. Its system unifies external asset scouting, scientific evaluation of licensing candidates, indication selection for clinical trials, and clinical data analysis within a single, traceable…